108 related articles for article (PubMed ID: 14577345)
1. [Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
Ito K; Hashimoto K; Ogata H
Kekkaku; 2003 Sep; 78(9):587-90. PubMed ID: 14577345
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1996 Apr; 49(4):377-85. PubMed ID: 8786628
[TBL] [Abstract][Full Text] [Related]
3. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
Hikida M; Terashima S; Sato Y; Okamoato R; Inoue M
Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603
[TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Kinoshita S; Kumagai S
Jpn J Antibiot; 1998 Sep; 51(9):551-60. PubMed ID: 9846282
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of antibiotics by the method of initial bactericidal activity].
Matsuda K; Inoue M
Jpn J Antibiot; 2000 Dec; 53(12):667-71. PubMed ID: 11234223
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial activities of meropenem against clinically isolated strains in 1997].
Suzuki Y; Matsumoto Y; Nishinari C; Endo H; Ishihara R; Deguchi K
Jpn J Antibiot; 1999 Dec; 52(12):695-720. PubMed ID: 10695025
[TBL] [Abstract][Full Text] [Related]
7. [Antibacterial activity of biapenem against recent clinical isolates].
Hara T; Araake M; Watabe H
Jpn J Antibiot; 2003 Apr; 56(2):138-41. PubMed ID: 12825414
[TBL] [Abstract][Full Text] [Related]
8. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
Abe T; Fukuoka T; Sato Y; Ito K; Sei M
Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735
[TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial activities of meropenem against clinically isolated strains].
Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1996 Feb; 49(2):175-93. PubMed ID: 8721078
[TBL] [Abstract][Full Text] [Related]
10. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
[TBL] [Abstract][Full Text] [Related]
11. [Bactericidal activity of biapenem against various bacteria].
Hiraishi T; Miyata A; Hara T; Araake M; Ogawa H
Jpn J Antibiot; 2001 Dec; 54(12):581-95. PubMed ID: 11877858
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Nukiwa T; Shoji S; Honda Y
Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024
[TBL] [Abstract][Full Text] [Related]
13. [In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Fukuoka T; Inoue H; Abe T; Ohya S
Jpn J Antibiot; 2001 Jul; 54(7):365-71. PubMed ID: 11560055
[TBL] [Abstract][Full Text] [Related]
14. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
15. [Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
Arita K; Daido K; Ohashi N; Nakamura K; Takeshima Y; Kohara T
Jpn J Antibiot; 1999 Jul; 52(7):491-6. PubMed ID: 10516928
[TBL] [Abstract][Full Text] [Related]
16. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
[TBL] [Abstract][Full Text] [Related]
17. [The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
Fujiue Y; Kuwabara M; Muroki K; Shimizu S; Watanabe Y; Awaya Y; Kodomari Y
Jpn J Antibiot; 1998 Jan; 51(1):26-36. PubMed ID: 9557274
[TBL] [Abstract][Full Text] [Related]
18. Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
Kaushik A; Gupta C; Fisher S; Story-Roller E; Galanis C; Parrish N; Lamichhane G
Future Microbiol; 2017 May; 12(6):473-480. PubMed ID: 28326811
[TBL] [Abstract][Full Text] [Related]
19. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
[TBL] [Abstract][Full Text] [Related]
20. [Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
Suzuki Y; Nishinari C; Endo H; Tamura C; Jinbo K
Jpn J Antibiot; 2001 Sep; 54(9):473-90. PubMed ID: 11729712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]